BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 24, 2003
View Archived Issues
GelTex claims new lipase inhibitors with utility in obesity
Read More
Novel HGF receptor tyrosine kinase inhibitors described by Kirin Brewery
Read More
JT researchers identify novel HCV NS5B inhibitors
Read More
New antidiabetic DPP-IV inhibitors in early development at Ferring
Read More
Akzo Nobel claims quinoline-based modulators of FSH receptors
Read More
New PPAR modulators in Biovitrum research pipeline
Read More
Schering presents novel agents able to inhibit microglia activation
Read More
Nevirapine reported to be as effective as efavirenz and possibly safer in HIV infection
Read More
New data on fosamprenavir in HIV infection
Read More
GBV-C coinfection associated with improved survival of HIV-infected patients
Read More
Antiretroviral effects of TMC-114 plus ritonavir in PI-experienced HIV patients
Read More
Antiviral efficacy of peginterferon alfa-2b in early HIV infection
Read More
Adalimumab reported to increase the efficacy of methotrexate in rheumatoid arthritis
Read More
Enhanced atherosclerotic plaque stability reported after fish oil administration
Read More
Initiation of phase II for ramoplanin in Clostridium difficile-associated diarrhea
Read More
Eunoe initiates phase III trial of COGNIShunt System
Read More
Pennsaid marketing applications filed in E.U. countries
Read More
FDA grants priority review to Cidecin NDA
Read More
DAC:GLP-1 clinical program resumes
Read More
Metformin XT NDA accepted for filing by FDA
Read More
Phase I results for Neugene antisense drug AVI-4557
Read More
Biosite enters collaboration with Neurocrine Biosciences
Read More
Kaken and Elitra team up for antifungal discovery and development collaboration
Read More
Antiinflammatory properties documented for small-molecule MC1 receptor agonist
Read More
Peptidomimetic delta opioid receptor-selective agonist as a systemically active analgesic
Read More